Clinical Trials Directory

Trials / Terminated

TerminatedNCT00438139

Ph1 Marinol Interaction Study - Part 1 - 1

Phase 1, Pilot Study to Examine the Cardiovascular Effects of Smoked Marijuana, Interactions With Oral Dronabinol, and Effects of Dronabinol on Withdrawal in Marijuana Dependent Volunteers

Status
Terminated
Phase
Phase 1
Study type
Interventional
Enrollment
6 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

The purpose of this study is to examine the effects of oral dronabinol tetrahydrocannabinol (THC) on withdrawal symptoms in marijuana dependent volunteers, and evaluate the safety, pharmacokinetics (PK), and cardiovascular effects of the combination of oral dronabinol and smoked marijuana to determine if there are potential significant interactions before conducting outpatient studies.

Conditions

Interventions

TypeNameDescription
DRUGDronabinol

Timeline

Start date
2007-03-01
Primary completion
2007-03-01
Completion
2007-03-01
First posted
2007-02-21
Last updated
2017-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00438139. Inclusion in this directory is not an endorsement.

Ph1 Marinol Interaction Study - Part 1 - 1 (NCT00438139) · Clinical Trials Directory